Exagen (XGN) announced the appointment of Jeffrey Black, to the role of Chief Financial Officer, CFO, effective September 1, 2024. Black replaces Kamal Adawi, who will be stepping down, and John Aballi will act as interim CFO through the end of August. Black currently serves as CFO of Standard BioTools (LAB)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XGN: